Earnings Call · Q4 FY2021·2022-02-24

Q4 21EPS -22.00%·Rev n/aQ3 21EPS +72.92%·Rev n/aQ2 21EPS +22.00%·Rev n/aQ1 21EPS -83.33%·Rev n/a⚠ consensus missing

Travere Therapeutics, Inc. TVTX

Chris Cline — Investor Relations or Corporate Communications

Eric Dube — Chief Executive Officer

Jula Inrig — Chief Medical Officer or Medical Executive

Peter Heerma — Chief Commercial Officer

Laura Clague — Chief Financial Officer

+0.8%1d on move date+0.9% vs SPY3d−3.8%5d−1.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TVTX calls or request research access.

More TVTX calls Browse calls Request research access